Morningstar

Smith & Nephew PLC ADR SNN

Stock XNYS Rating as of Oct 21, 2026

News

Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal

GlobeNewswire Oct 6, 2026, 8:00:00 AM
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

GlobeNewswire Sep 23, 2026, 4:01:16 PM
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

GlobeNewswire Sep 23, 2026, 3:11:23 PM
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System

GlobeNewswire Sep 22, 2026, 12:00:00 PM
Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026

GlobeNewswire Sep 21, 2026, 2:00:00 PM
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds

ACCESS Newswire Sep 16, 2026, 9:45:00 AM
Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds

ACCESS Newswire Sep 15, 2026, 10:00:00 PM
Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m

ACCESS Newswire Sep 8, 2026, 12:40:00 PM
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics

GlobeNewswire Aug 18, 2026, 7:01:36 AM
Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options

GlobeNewswire Aug 17, 2026, 12:00:00 PM
Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week

GlobeNewswire Aug 5, 2026, 5:00:00 PM
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

GlobeNewswire Jul 29, 2026, 2:00:00 PM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.